During the 18 months of protected, structured research time, fellows can engage in a wide variety of research opportunities. These include laboratory, translation, and clinical research, quality improvement projects, health services or health outcomes research, and educational research. The purpose of this time is to help fellows develop a foundation for becoming leaders in their chosen field. Components of the research structure includes:
- Mentored Fellowship Tracks (Laboratory, Clinical/Translational, Clinician, Clinician Educator): Fellows will choose a track depending on their career goals, which will help to shape their 18 months of research time, including opportunities and expectations.
- Mentorship Committees: Fellows choose a mentorship committee at the end of their first year, which will include their research mentors, faculty advisor, and other mentors. The committee meets every 6 months with the fellow to review goals, progress, and opportunities.
- Supplemental education: Fellows may apply for tuition assistance from the Division for courses, certificates, or degrees at the University of Pittsburgh’s Institute for Clinical Research Education.
- Research in Progress Conferences: Fellows have the opportunity to present their research in progress once a year at these monthly conferences, with feedback provided by faculty and peers.
- A vast network of research mentors and opportunities. UPMC Hillman Cancer Center is also involved in clinical trials with the Eastern Cooperative Oncology Group (ECOG) and the National Surgical Adjuvant Breast and Bowel Project (NSABP), which is located in Pittsburgh.
- Benign Hematology track: Specialized track designed for fellows who aim for an academic career in hematology. This includes focused mentorship from benign hematology faculty, research opportunities through the Vascular Medicine Institute (VMI) or the Western Pennsylvania Chapter of the National Hemophilia Foundation, focused electives in benign hematology, and opportunity to be on a VMI T32 training grant
Here is an example of current fellows’ research projects:
- Phase II clinical trial evaluating aggressive local treatment for Oligometastatic HNSCC patients
- Tim 3 gene expression profile in breast cancer
- Immunotherapeutic Approaches for Acute Myeloid Leukemia
- Comprehensive Clinical & Molecular Characterization of Mixed Invasive Ductal Lobular carcinomas
- Development of a Benign Hematology E-Learning Case-Based Curriculum for Internal Medicine Residents and First-Year Hematology/Oncology Fellows
- Phase II Trial of Sulforaphane for Chemoprevention in Melanoma Patients with Multiple Atypical Nevi
- Neoadjuvant PD1 + TIM3 Inhibition in Locally Advanced/Oligometastatic Melanoma
- A Randomized Phase II Study of High Dietary Fiber in PD-1 Treated Metastatic Melanoma Patients